LAMC2 and pancreatic adenocarcinoma: The findings in our study are consistent with previous reports as we found that the LAMA3, LAMB3, and LAMC2 genes were upregulated in patients with PAAD, with hazard ratios of 3.86, 2.18, and 3.06, respectively.